A bivalent β-carboline derivative inhibits macropinocytosis-dependent entry of pseudorabies virus by targeting the kinase DYRK1A.

Autor: Wang C; College of Veterinary Medicine, Northwest A&F University, Xianyang, China., Hu R; College of Veterinary Medicine, Northwest A&F University, Xianyang, China., Wang T; College of Veterinary Medicine, Northwest A&F University, Xianyang, China., Duan L; College of Veterinary Medicine, Northwest A&F University, Xianyang, China., Hou Q; College of Veterinary Medicine, Northwest A&F University, Xianyang, China., Wang J; College of Chemistry and Pharmacy, Northwest A&F University, Xianyang, China. Electronic address: wangjunru@nwsuaf.edu.cn., Yang Z; College of Veterinary Medicine, Northwest A&F University, Xianyang, China. Electronic address: yzq1106@nwsuaf.edu.cn.
Jazyk: angličtina
Zdroj: The Journal of biological chemistry [J Biol Chem] 2023 Apr; Vol. 299 (4), pp. 104605. Date of Electronic Publication: 2023 Mar 12.
DOI: 10.1016/j.jbc.2023.104605
Abstrakt: Pseudorabies virus (PRV) has become a "new life-threatening zoonosis" since the human-originated PRV strain was first isolated in 2020. To identify novel anti-PRV agents, we screened a total of 107 β-carboline derivatives and found 20 compounds displaying antiviral activity against PRV. Among them, 14 compounds showed better antiviral activity than acyclovir. We found that compound 45 exhibited the strongest anti-PRV activity with an IC 50 value of less than 40 nM. Our in vivo studies showed that treatment with 45 significantly reduced the viral loads and protected mice challenged with PRV. To clarify the mode of action of 45, we conducted a time of addition assay, an adsorption assay, and an entry assay. Our results indicated that 45 neither had a virucidal effect nor affected viral adsorption while significantly inhibiting PRV entry. Using the FITC-dextran uptake assay, we determined that 45 inhibits macropinocytosis. The actin-dependent plasma membrane protrusion, which is important for macropinocytosis, was also suppressed by 45. Furthermore, the kinase DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A) was predicted to be a potential target for 45. The binding of 45 to DYRK1A was confirmed by drug affinity responsive target stability and cellular thermal shift assay. Further analysis revealed that knockdown of DYRK1A by siRNA suppressed PRV macropinocytosis and the tumor necrosis factor alpha-TNF-induced formation of protrusions. These results suggested that 45 could restrain PRV macropinocytosis by targeting DYRK1A. Together, these findings reveal a unique mechanism through which β-carboline derivatives restrain PRV infection, pointing to their potential value in the development of anti-PRV agents.
Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.
(Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: